How the Health Technology Access Programme (HTAP) Operates?
•February 24, 2026
0
Why It Matters
HTAP enhances global health security by diversifying production sources, lowering costs and accelerating access to life‑saving technologies in underserved regions.
Key Takeaways
- •HTAP builds regional manufacturing to reduce reliance on global suppliers
- •Program secures licenses and know‑how for local production of essential health products
- •Partnerships enable malaria and HIV test manufacturing in Nigeria
- •HTAP leverages WHO convening power to coordinate full health‑technology value chain
- •Strengthening local capacity improves health security and creates sustainable market access
Summary
The World Health Organization’s Health Technology Access Programme (HTAP) is designed to close the gap between high‑income manufacturers and low‑ and middle‑income countries that struggle with limited production capacity, skilled workforces, and costly health products. By convening technology owners, local manufacturers, governments and experts, HTAP seeks to ensure medicines, vaccines and diagnostics reach communities when they are needed most.
HTAP tackles fragile supply chains by securing licenses, transferring know‑how and establishing research‑development consortia that can co‑create technologies such as mRNA‑based influenza vaccines. The programme scans priority health needs, matches partners across the value chain, and provides training, regulatory assistance and market‑access support to build sustainable regional manufacturing hubs.
A flagship collaboration, supported by the WHO‑managed patent pool, pairs Singapore‑based SD Bioensor with Nigeria’s Codex Bio to produce malaria and HIV diagnostic tests locally. The same platform can be repurposed for future pandemics, illustrating how technology transfer creates immediate and adaptable health solutions.
For governments, HTAP strengthens health‑system resilience and reduces dependence on a narrow set of global suppliers. Technology holders gain market expansion and reputational benefits, while local manufacturers acquire scalable expertise. Ultimately, the programme advances equity by making essential health technologies more affordable and reliably available worldwide.
Original Description
Amid new health threats and enduring inequities, how do we ensure medicines, vaccines and medical devices reach every community when they're needed most?
The World Health Organization's Health Technology Access Programme (HTAP) advances this mission by strengthening regional manufacturing and building global resilience.
Coordinating across the entire value chain, HTAP secures licenses and know-how for proven products, enabling local partners to manufacture them. The programme also creates research and development consortia to jointly develop new technologies.
HTAP brings together technology holders, local manufacturers, international experts and governments to promote equity, reducing dependence on a few global suppliers of health products—empowering regions to meet their own health needs.
0
Comments
Want to join the conversation?
Loading comments...